14
Aug
Penn Medicine launched an innovative clinical trial in 2016 to test the effect of transplanting kidneys from donors with Hepatitis C virus (HCV) into patients currently on the kidney waitlist who do not have the virus and would opt in to receive these otherwise unused organs. After transplantation, recipients were treated with an antiviral therapy in an effort to cure the virus. To date, 20 patients have...
Read More